CAV1 and familial hypercholesterolemia: In the AP-CAV-1 treated rabbits, CAV-1 protected the hypercholesterolemia-associated and altered mitochondrial morphology, as demonstrated by the dark matrix and integrated mitochondrial membranes (Fig 3B).